55.99 USD
-0.41 (-0.73%)
56.1 USD
+0.11 (+0.2%)
MDLZ gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 87 industry peers in the Food Products industry. MDLZ scores excellent on profitability, but there are concerns on its financial health. MDLZ has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year MDLZ was profitable.
In the past year MDLZ had a positive cash flow from operations.
In the past 5 years MDLZ has always been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
1.2 Ratios
MDLZ has a better Return On Assets (4.95%) than 73.56% of its industry peers.
MDLZ's Return On Equity of 13.49% is amongst the best of the industry. MDLZ outperforms 81.61% of its industry peers.
The Return On Invested Capital of MDLZ (6.25%) is better than 66.67% of its industry peers.
MDLZ had an Average Return On Invested Capital over the past 3 years of 7.83%. This is significantly below the industry average of 28.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
The Profit Margin of MDLZ (9.38%) is better than 86.21% of its industry peers.
MDLZ's Profit Margin has declined in the last couple of years.
The Operating Margin of MDLZ (11.59%) is better than 78.16% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a better Gross Margin (31.05%) than 72.41% of its industry peers.
MDLZ's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
MDLZ has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MDLZ has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.27 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score (2.27) which is in line with its industry peers.
The Debt to FCF ratio of MDLZ is 9.31, which is on the high side as it means it would take MDLZ, 9.31 years of fcf income to pay off all of its debts.
MDLZ's Debt to FCF ratio of 9.31 is fine compared to the rest of the industry. MDLZ outperforms 63.22% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that MDLZ is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.76, MDLZ is doing worse than 62.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.27 |
ROIC/WACC0.84
WACC7.4%
2.3 Liquidity
MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.61, MDLZ is not doing good in the industry: 88.51% of the companies in the same industry are doing better.
A Quick Ratio of 0.37 indicates that MDLZ may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.37, MDLZ is doing worse than 82.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.70%.
Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.91% on average per year.
Looking at the last year, MDLZ shows a small growth in Revenue. The Revenue has grown by 4.13% in the last year.
Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.09% on average per year.
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.92% yearly.
MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.65 indicates a rather expensive valuation of MDLZ.
The rest of the industry has a similar Price/Earnings ratio as MDLZ.
MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.15.
The Price/Forward Earnings ratio is 17.13, which indicates a rather expensive current valuation of MDLZ.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.22, MDLZ is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.65 | ||
| Fwd PE | 17.13 |
4.2 Price Multiples
MDLZ's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 31.55 | ||
| EV/EBITDA | 15.8 |
4.3 Compensation for Growth
MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.84
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
5. Dividend
5.1 Amount
MDLZ has a Yearly Dividend Yield of 3.50%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.06, MDLZ pays a bit more dividend than its industry peers.
MDLZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
5.2 History
On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
MDLZ pays out 69.92% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
55.99
-0.41 (-0.73%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners88.19%
Inst Owner Change3.24%
Ins Owners0.14%
Ins Owner Change-0.01%
Market Cap72.25B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts75.88
Price Target70.11 (25.22%)
Short Float %2.39%
Short Ratio3.65
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.5% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-3.66%
PT rev (3m)-6.75%
EPS NQ rev (1m)-15.47%
EPS NQ rev (3m)-12.77%
EPS NY rev (1m)-2.89%
EPS NY rev (3m)-3.15%
Revenue NQ rev (1m)-0.92%
Revenue NQ rev (3m)-1.16%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-0.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.65 | ||
| Fwd PE | 17.13 | ||
| P/S | 1.92 | ||
| P/FCF | 31.55 | ||
| P/OCF | 20.2 | ||
| P/B | 2.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.8 |
EPS(TTM)2.85
EY5.09%
EPS(NY)3.27
Fwd EY5.84%
FCF(TTM)1.77
FCFY3.17%
OCF(TTM)2.77
OCFY4.95%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.84
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.27 |
F-Score5
WACC7.4%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year11.05%
EBIT Next 3Y8.25%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 5 / 10 to MDLZ.
What is the valuation status for MDLZ stock?
ChartMill assigns a valuation rating of 4 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Fairly Valued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
What are the PE and PB ratios of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 19.65 and the Price/Book (PB) ratio is 2.76.
How financially healthy is MONDELEZ INTERNATIONAL INC-A?
The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.